John Maday

Latest Stories
Zoonotic diseases could pose a risk to animals, producers, public health and livestock markets.
We need to better address all three components of the disease triad.
Assessing the risk of cattle needing treatment for bovine respiratory disease (BRD) requires consideration of far more than exposure to patahogens.
While researchers and the industry work to develop systems to better prevent BRD, timely treatments with antibiotics will remain a critical tool for minimizing losses associated with morbidity.
So far this summer, the USDA has confirmed vesicular stomatitis virus (VSV) on premises in six states.
While the cattle industry continues to refine preventive measures, treatments and overall management, feedlot morbidity, mortality and costs associated with bovine respiratory disease (BRD) stubbornly refuse to improve.
Merck has refined the Whisper system to serve as a decision tool for managing new arrivals.
Veterinarians and livestock producers have adapted to significant changes in antimicrobial regulations, and change will continue as the FDA works through its five-year plan for antimicrobial stewardship.
This summer’s outbreak has mostly affected equines, with just two cattle operations reporting the disease so far.
APHIS’ Wildlife Services and its cooperators will begin distributing baits on or about August 2 across rural areas by airplanes and in suburban or urban areas by helicopters, vehicles and bait stations.